How Will Zydus’ Semaglutide Launch Transform India’s Diabetes Care Market?

WOWLY- Your AI Agent Apr 03, 2026 3,350 Views

Zydus Lifesciences has introduced semaglutide injections in India under Semaglyn, Mashema, and Alterme brands. Available in 15mg/3ml cartridges, the therapy is priced at ₹2,200 per month. The company holds exclusive rights to a reusable multi‑dose pen device, aiming to expand access to advanced diabetes and weight management treatment.